The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IACH Focus on Leukemia 2020 | The resurgence in acute leukemia research development
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses the online congress this year and its focus on acute leukemia. In the last few years, there has been a resurgence in acute leukemia research due to a development in molecular biological technology, next-generation sequencing (NGS) and refinement in diagnosis. Despite the development in novel treatments, for some acute myeloid leukemia (AML) patients who relapse, allogeneic hematopoietic cell transplantation still remains the only valid option. This interview took place during the 2020 Annual Meeting of the International Academy for Clinical Hematology (IACH).
